Observational Examination of Thermoregulation in Total Joint Arthroplasty

Status Completed

Clinical Trial Summary

Total joint patients have poor outcomes with infection since they are having permanent hardware implanted. Infection prevention in this group is therefore critical and a major source of discussion in both the orthopedic and anesthesia literature.

Hypothermia has been shown to increase the risk of infection and blood loss. However, studies have not examined when in the operation or how fast patients temperatures drop. This study will observe how patients' temperatures change during total joint arthroplasty. By identifying when body temperature changes occur, prevention strategies may be developed and implemented.

Clinical Trial Description

Peri-operative hypothermia can have deleterious effects. While there is no standard consistent definition within the literature mild hypothermia is commonly defined as a core temperature between 34 and 36 °C. Mild hypothermia has been shown to increase the occurrence of surgical site infections, cardiac morbidity, coagulopathy leading to increased blood loss and transfusion requirements, impaired drug metabolism, and prolonged emergence from anesthesia. In addition, there is evidence that maintaining intra-operative normothermia can shorten hospital length of stay. Despite the fact that intra-operative temperature monitoring and warming are considered standard of care, peri-operative hypothermia in total joint arthroplasty patients remains an issue for several reasons. A large proportion of patient undergoing joint replacement are elderly, making them susceptible to peri-operative hypothermia. In addition, regional anesthesia causes vasodilation and promotes heat flow from the core to the periphery and impairs central and autonomic thermoregulation such that patients receiving neuraxial anesthesia can be particularly susceptible to perioperative hypothermia. Finally, core temperature monitoring is typically not used during regional anesthesia and hypothermia may go undetected for long periods of time.

The primary goal of this study was to examine the incidence of hypothermia during lower extremity arthroplasty. A secondary aim was to identify patient and operative factors associated with hypothermia in order to improve future preventative strategies. Our hypothesis was that peri-operative hypothermia occurs in the majority of patients undergoing lower extremity arthroplasty. In addition, we hypothesized that certain patient and anesthetic factors (such as low body mass index and receiving general anesthesia) would increase the incidence of hypothermia. ;

Study Design

Related Conditions & MeSH terms

Hypothermia

Clinical Trial Details

NCT number	NCT02225743
Study type	Observational
Source	Medical University of South Carolina
Contact
Status	Completed
Phase
Start date	August 2014
Completion date	June 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05669313` - The Effects of Hypothermia and Acidosis on Coagulation During Treatment With Rivaroxaban Measured With ROTEM
Not yet recruiting	`NCT05306392` - Effects of Induced Moderate Hypothermia on ARDS Patients Under Venovenous ExtraCorporeal Membrane Oxygenation	N/A
Completed	`NCT02685176` - Head and Torso Rewarming Using a Human Model for Severe Hypothermia	N/A
Completed	`NCT02586974` - Effects of Warmed, Humidified CO2 Insufflation on Body Core Temperature and Cytokine Response	N/A
Withdrawn	`NCT02812069` - WarmSmart Warming Protocol	N/A
Completed	`NCT02177903` - Study to Determine the Effects of Pre-warming on OR Patient Temperatures and Surgical Outcomes	N/A
Not yet recruiting	`NCT02211703` - National Epidemiologic Survey on the Incidence of Perioperative Hypothermia	N/A
Completed	`NCT02121574` - Accuracy of Zero-flux and Ingestible Thermometers	N/A
Completed	`NCT02742818` - Forced-air Warming in Endovascular Surgery: Testing Effectiveness of Two Different Blanket Models	N/A
Recruiting	`NCT01866384` - Targeted Temperature Management After Intracerebral Hemorrhage	Phase 2
Active, not recruiting	`NCT01529658` - Renal Hypothermia During Partial Nephrectomy	N/A
Completed	`NCT01722955` - Pre-warmed Intravenous Fluids and Monitored Anesthesia Care	N/A
Completed	`NCT01793337` - Core Body Temperature Measurement During Hot and Cold Environmental Exposure	N/A
Completed	`NCT01559675` - Trial Comparing Low Dose and High Dose Steroids in Patients Undergoing Colorectal Surgery	N/A
Terminated	`NCT01018576` - Delayed Cord Clamping in Premature Infants	N/A
Completed	`NCT00904228` - Plastic Hat Trial to Prevent Hypothermia in Preterm Newborns in the Delivery Room	N/A
Terminated	`NCT00822796` - Thermogard™ Efficacy Trial	N/A
Completed	`NCT00334360` - Dexmed/Buspirone Synergism on Shivering	Phase 4
Not yet recruiting	`NCT06283771` - The Effect of Heated Socks Developed With Wearable Technology on Hypothermia, Thermal Comfort Perception and Shivering	N/A
Completed	`NCT04399902` - Study to Actively Warm Trauma Patients	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.